newsfilter
← Latest News
GlobeNewswire·

Zevra Therapeutics to Participate in the Canaccord Genuity 45th Annual Growth Conference

CELEBRATION, Fla., Aug. 06, 2025 (GLOBE NEWSWIRE) -- Zevra Therapeutics, Inc. (NASDAQ:ZVRA) (Zevra, or the Company), a commercial-stage company focused on providing therapies for people living with rare disease, today